The role of indoleamine-2,3-dioxygenase in development of antitumor immune response tiggered by photodynamic therapy

2014/13/D/NZ6/01080

Keywords

Descriptors

  • NZ6_8: Inne zagadnienia pokrewne
  • NZ1_1: Biologia molekularna
  • NZ5_9: Inne zagadnienia pokrewne

Panel

NZ6 – Human and animal immunology and infection: immunity, immune disorders, immunotherapy, infectious and invasive diseases, microbiology, transplantology, allergology

Host institution

Warszawski Uniwersytet Medyczny, I Wydział Lekarski

Voivodeship: mazowieckie

Other projects carried out by the institution »

Principal investigator (from the host institution)

dr Angelika Muchowicz

Number of co-investigators in the project: 2

Call

SONATA 7 – announced on 2014-03-17

Amount awarded
691 987 PLN
Project start date
2015-02-02
Project end date
2018-08-01
Project duration
42 months (the same as in the proposal)
Project status
Project settled

Information in the final report

Publication in academic press/journals (2)

  1. Inhibition of lymphangiogenesis impairs antitumour effects of photodynamic therapy and checkpoint inhibitors in mice

    Authors:
    Angelika Muchowicz, Malgorzata Wachowska, Joanna Stachura, Katarzyna Tonecka, Magdalena Gabrysiak, Dominika Wołosz, Zofia Pilch, Witold W. Kilarski, Louis Boon, Tomasz J. Klaus, Jakub Golab
    Academic press:
    European Journal of Cancer (year: 2017, volume: 2017 Sep;83:, pages: 19-27), Publisher: Elsevier
    Status:
    Published
    DOI:
    10.1016/j.ejca.2017.06.004. – link to the publication
  2. Inhibition of IDO leads to IL-6-dependent systemic inflammation in mice when combined with photodynamic therapy

    Authors:
    Malgorzata Wachowska, Joanna Stachura, Katarzyna Tonecka, Klaudyna Fidyt, Agata Braniewska, Zuzanna Sas, Iwona Kotula, Tomasz P Rygiel, Louis Boon, Jakub Golab, Angelika Muchowicz
    Status:
    Accepted for publication

« New search

Graphic design and implementation: Jakub Piotrowski